Autoimmune, pemphigus, dermatology, medical odyssey, oral health mystery, oral health, blisters, OASIS, Lupus, Sjogren's, ...

(NASDAQ:ARGX – Get Free Report) was upgraded by investment analysts at Sanford C. Bernstein from a “market perform” rating to ...

Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 13.80%, which has investors questioning if this is right time to buy.

Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin.

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses the concept of an immune reset and what the company is tracking in ...

Artiva Biotherapeutics' CEO Fred Aslan, MD, discusses two ongoing trials for autoimmunity indications in the US and how AlloNK differs from traditional B-cell depletion strategies.

Shares of Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) have received a consensus rating of “Buy” from the six ratings firms that are covering the company, MarketBeat.com reports. Six ...

Hello there, Teddy here! I'm a 6 month old kitten looking for my forever home. I'm a playful boy who enjoys other cats and ...

When humans bite their nails, it’s usually dismissed as a nervous tick or a bad habit. At worst, it is thought of as impolite ...

We present this case to (1) alert clinicians to potential complications when patch-testing patients with pemphigus and other immunobullous disorders and (2) review documented adverse events or ...